Defining SaeR/S-dependent Neutrophil-S. aureus Interactions that Determine the Outcome of Infection
定义 SaeR/S 依赖性中性粒细胞-S。
基本信息
- 批准号:10624864
- 负责人:
- 金额:$ 60.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-16 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:Antibiotic ResistanceAntibioticsApoptosisAutophagocytosisBacterial GenesBacterial InfectionsCell CommunicationCell Culture SystemCell Culture TechniquesCellsCommunitiesComplementCytolysisDataDevelopmentDiseaseDrug resistanceEffectivenessEnvironmentEventFoundationsFunctional disorderFutureGene ExpressionGenesGenetic TranscriptionHigh PrevalenceHospitalsHumanImmuneImmune responseImmunotherapeutic agentIndividualInfectionInflammation MediatorsIntelligenceLifeLinkMediatingMethodsModelingMolecularMorbidity - disease rateNatural ImmunityNecrotizing fasciitisNeutrophil InfiltrationOutcomeOutpatientsPathogenesisPathway interactionsPeripheral Blood Mononuclear CellPeroxidasesPhagocytosisPlayPopulationProductionPublic HealthPublishingRNAReactive Oxygen SpeciesRegulationRegulator GenesReportingResearchResistance developmentRiskRoleSepsisSeveritiesSignal TransductionSkinSoft Tissue InfectionsStaphylococcus aureusStaphylococcus aureus infectionSystemTNF geneTestingTherapeuticTimeTranscriptUp-RegulationVaccinesVirulenceVisitantimicrobialclinically significantcombatcommunity settingdesignemerging pathogenexperimental studyextracellularimprovedin vivoleukotoxinmonocytemortalitymouse modelneutrophilnext generation sequencingnovelnovel therapeuticsnovel vaccinespathogenpreventresponsesensory systemskin abscesstranscriptometranscriptome sequencingvirulence gene
项目摘要
Staphylococcus aureus (S. aureus) is one of the most frequent causes of bacterial infections in the U.S. and is
responsible for diverse types of infections ranging in severity from mild to fatal in both hospital and community
settings. In the community, S. aureus typically causes skin-and-soft-tissue infections with an estimated 12 –
13 million outpatient visits per-year (in the U.S.) but can also cause severe manifestations including necrotizing
fasciitis and sepsis in individuals with no underlying risk. One of the most clinically significant aspects of S.
aureus infections is the high prevalence of drug resistance and the innate ability for S. aureus to develop
resistance to antibiotics making it very difficult to develop therapeutics that will have potential for long-term
efficacy on S. aureus. The research proposed in this application will broaden our understanding of host-
pathogen interactions, providing the foundation for future studies aimed at the intelligent design of novel
vaccines and therapies to treat bacterial infection. To that end, this project will study how S. aureus uses the
SaeR/S two-component gene regulatory system to evade innate immunity. The SaeR/S system is essential for
evasion of neutrophil killing; however, exact mechanisms dependent on SaeR/S resulting in neutrophil
dysfunction are not defined. Three specific Aims will test the hypothesis that the SaeR/S-mediated up-
regulation of S. aureus virulence genes undermines an effective neutrophil response that would normally clear
infection. In Aim One, host pathogen RNA expression via RNA-seq will be used to determine the direct
influence of SaeR/S-regulated bacterial genes on human neutrophil gene expression as well as resolve the
individual contribution of SaeR/S components on neutrophil and pathogen gene expression simultaneously. In
Aim Two, we will determine how SaeR/S-dependent changes in neutrophil human myeloperoxidase (MPO)
activity and the production reactive oxygen species (ROS) alters neutrophil apoptosis and neutrophil
extracellular trap (NET) formation. In Aim Three, we will utilize a novel ex vivo model of neutrophil priming by
stimulated PBMCs to determine the role of initial SaeR/S-mediated immune cell interactions on subsequent
neutrophil function. These ex vivo primary human cell studies will be complemented with murine models of
infection to thoroughly evaluate these immune responses. Findings from experiments outlined in this proposal
will improve our overall understanding of host-pathogen interactions by specifically characterizing novel
SaeR/S-mediated mechanisms used by S. aureus to overcome an effective neutrophil response. Collectively
this research will address our long-term objective to characterize reciprocal response pathways between host
and pathogen that will highlight key factors needed for both the pathogen to cause infection and for the host to
resolve disease. Results will provide valuable information for vaccine and immunotherapeutic development.
金黄色葡萄球菌(S.金黄色葡萄球菌)在美国是细菌感染的最常见原因之一,
在医院和社区中引起严重程度从轻度到致命的各种类型的感染
设置.在社区中,S.金黄色葡萄球菌通常引起皮肤和软组织感染,
每年1300万次门诊就诊(在美国)但也可引起严重的表现
在没有潜在风险的个体中发生筋膜炎和脓毒症。S.
金黄色葡萄球菌感染的主要原因是耐药率高和S.金黄色葡萄球菌培养
对抗生素的耐药性使得很难开发具有长期潜力的治疗方法
对S.金黄色。本申请中提出的研究将拓宽我们对宿主细胞的认识。
病原体相互作用,为未来研究提供了基础,旨在智能设计新的
疫苗和治疗细菌感染的疗法。为此,本项目将研究S.金黄色葡萄球菌使用
SaeR/S双组分基因调控系统逃避先天免疫。SaeR/S系统对于以下操作至关重要:
逃避中性粒细胞杀伤;然而,确切机制依赖于SaeR/S,导致中性粒细胞
功能障碍未被定义。三个特定的目的将检验SaeR/S介导的上调表达的假设。
S.金黄色葡萄球菌毒力基因破坏了正常情况下
感染在第一个目的中,通过RNA-seq的宿主病原体RNA表达将用于确定直接的
SaeR/S调控的细菌基因对人中性粒细胞基因表达的影响及解决
SaeR/S组分对嗜中性粒细胞和病原体基因同时表达个体贡献。在
第二,我们将确定SaeR/S依赖性变化是如何影响中性粒细胞人髓过氧化物酶(MPO)
活性氧(ROS)的产生改变了中性粒细胞凋亡和中性粒细胞
细胞外陷阱(NET)形成。在第三个目标中,我们将利用一种新的中性粒细胞体外启动模型,通过
刺激的PBMC,以确定初始SaeR/S介导的免疫细胞相互作用对后续
中性粒细胞功能。这些离体原代人细胞研究将用以下鼠模型进行补充
以彻底评估这些免疫应答。本提案中概述的实验结果
将提高我们对宿主-病原体相互作用的全面理解,通过特异性地鉴定新的
SaeR/S介导的S.以克服有效嗜中性白细胞应答。集体
这项研究将致力于我们长期目标,以确定宿主之间的相互反应途径
和病原体,这将突出病原体引起感染以及宿主
解决疾病。研究结果将为疫苗和免疫治疗的开发提供有价值的信息。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Experimental Designs to Study the Aggregation and Colonization of Biofilms by Video Microscopy With Statistical Confidence.
- DOI:10.3389/fmicb.2021.785182
- 发表时间:2021
- 期刊:
- 影响因子:5.2
- 作者:Pettygrove BA;Smith HJ;Pallister KB;Voyich JM;Stewart PS;Parker AE
- 通讯作者:Parker AE
Further Insight into the Mechanism of Human PMN Lysis following Phagocytosis of Staphylococcus aureus.
在金黄色葡萄球菌吞噬作用后,进一步了解了人类PMN裂解的机制。
- DOI:10.1128/spectrum.00888-21
- 发表时间:2021-10-31
- 期刊:
- 影响因子:3.7
- 作者:Rungelrath V;Porter AR;Malachowa N;Freedman BA;Leung JM;Voyich JM;Otto M;Kobayashi SD;DeLeo FR
- 通讯作者:DeLeo FR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tyler K Nygaard其他文献
Tyler K Nygaard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tyler K Nygaard', 18)}}的其他基金
Defining SaeR/S-dependent Neutrophil-S. aureus Interactions that Determine the Outcome of Infection
定义 SaeR/S 依赖性中性粒细胞-S。
- 批准号:
10408775 - 财政年份:2020
- 资助金额:
$ 60.9万 - 项目类别:
Defining SaeR/S-dependent Neutrophil-S. aureus Interactions that Determine the Outcome of Infection
定义 SaeR/S 依赖性中性粒细胞-S。
- 批准号:
10194360 - 财政年份:2020
- 资助金额:
$ 60.9万 - 项目类别:
Defining SaeR/S-dependent Neutrophil-S. aureus Interactions that Determine the Outcome of Infection
定义 SaeR/S 依赖性中性粒细胞-S。
- 批准号:
10058515 - 财政年份:2020
- 资助金额:
$ 60.9万 - 项目类别:
相似海外基金
Can antibiotics disrupt biogeochemical nitrogen cycling in the coastal ocean?
抗生素会破坏沿海海洋的生物地球化学氮循环吗?
- 批准号:
2902098 - 财政年份:2024
- 资助金额:
$ 60.9万 - 项目类别:
Studentship
Metallo-Peptides: Arming Cyclic Peptide Antibiotics with New Weapons to Combat Antimicrobial Resistance
金属肽:用新武器武装环肽抗生素以对抗抗菌素耐药性
- 批准号:
EP/Z533026/1 - 财政年份:2024
- 资助金额:
$ 60.9万 - 项目类别:
Research Grant
The role of RNA repair in bacterial responses to translation-inhibiting antibiotics
RNA修复在细菌对翻译抑制抗生素的反应中的作用
- 批准号:
BB/Y004035/1 - 财政年份:2024
- 资助金额:
$ 60.9万 - 项目类别:
Research Grant
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
- 批准号:
EP/Y023528/1 - 财政年份:2024
- 资助金额:
$ 60.9万 - 项目类别:
Research Grant
Towards the sustainable discovery and development of new antibiotics
迈向新抗生素的可持续发现和开发
- 批准号:
FT230100468 - 财政年份:2024
- 资助金额:
$ 60.9万 - 项目类别:
ARC Future Fellowships
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
- 批准号:
BB/Y007611/1 - 财政年份:2024
- 资助金额:
$ 60.9万 - 项目类别:
Research Grant
The disulfide bond as a chemical tool in cyclic peptide antibiotics: engineering disulfide polymyxins and murepavadin
二硫键作为环肽抗生素的化学工具:工程化二硫多粘菌素和 murepavadin
- 批准号:
MR/Y033809/1 - 财政年份:2024
- 资助金额:
$ 60.9万 - 项目类别:
Research Grant
Role of phenotypic heterogeneity in mycobacterial persistence to antibiotics: Prospects for more effective treatment regimens
表型异质性在分枝杆菌对抗生素持久性中的作用:更有效治疗方案的前景
- 批准号:
494853 - 财政年份:2023
- 资助金额:
$ 60.9万 - 项目类别:
Operating Grants
Imbalance between cell biomass production and envelope biosynthesis underpins the bactericidal activity of cell wall -targeting antibiotics
细胞生物量产生和包膜生物合成之间的不平衡是细胞壁靶向抗生素杀菌活性的基础
- 批准号:
2884862 - 财政年份:2023
- 资助金额:
$ 60.9万 - 项目类别:
Studentship
Narrow spectrum antibiotics for the prevention and treatment of soft-rot plant disease
防治植物软腐病的窄谱抗生素
- 批准号:
2904356 - 财政年份:2023
- 资助金额:
$ 60.9万 - 项目类别:
Studentship